Our corporate investigations coverage identifies companies and industries that may be impacted by new or existing laws and regulations. For individual companies, we report on specific business practices that may pose legal or regulatory risks. Our industry-focused content examines new regulations that may materially affect an entire industry, as well as identifying the companies within the industry likely to be most impacted. Our journalists understand the impact regulatory agency actions can have on financial markets and provide insights on the potential results of regulatory actions, whether they include fines or material changes to a company’s business or an industry’s operation.
PDF
CONTACT US
Eli Lilly (LLY) is battling with the Food and Drug Administration in court over the status of its next-generation GLP-1 weight-loss drug,...
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • CMS probes pharmacy vertical integration, specialty drug pricing in request...
Equitable Holdings (EQH) and Corebridge Financial (CRBG) seek to become one company with a combined 12 insurers and reinsurers, over 12 million customers and $1.5 trillion assets under management by the end of the...
Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Real estate commissions remain unchanged two years after settlement,...
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Corcept Therapeutics says alleged off-label drug promotion doesn’t...
A vast web of reinsurance transactions has reshaped who stands behind Americans’ life insurance and retirement promises, with traditionally conservative corners of the industry increasingly dependent on the success of private equity firms and their investment strategies, a Capitol Forum...
This is The Capitol Forum’s Big Tech tracker, where we follow investigations and other proceedings targeting technology giants like Apple (AAPL), Alphabet (GOOG), Meta (META) and more across the EU. Here, we monitor and bring you up to date on cases launched under the bloc’s Digital...
In the wake of recent FDA scrutiny of microbial contamination in Medline (MDLN) products and several related recalls, FDA investigators found during a July inspection that the company has substandard processes for testing drug products for microbial contamination at its Mundelein,...
Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Enova shelves attempt to gain federal banking charter. • Warren says a...
The Capitol Forum’s corporate investigations team has demonstrated a consistent track record of successfully identifying companies that have legal, regulatory, or business risk.
DOWNLOAD PDF
Partner and Antitrust Chair, Fried Frank
"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."
Founding Partner, Geradin Partners; Professor of Competition Law and Economics, Tilburg University
“The Capitol Forum’s European coverage stands out for its depth, accuracy, and timeliness. Their investigative reporting and analysis on antitrust, corporate conduct, and regulatory developments offer valuable insights for practitioners and academics alike. As someone deeply engaged in European competition law, I’ve found their work to be consistently thoughtful and impactful.”
Partner, Willkie Farr & Gallagher
"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."
Partner, Fenwick & West
"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."
